Hosoda; Hiroshi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hosoda; Hiroshi.The latest application filed is for "medicament for preventing or inhibiting acute kidney injury".
- Hosoda; Hiroshi - Chiba N/A JP
- Hosoda; Hiroshi - Osaka JP
- Hosoda; Hiroshi - Suita JP
- Hosoda; Hiroshi - Minoo N/A JP
- HOSODA; Hiroshi - Suita-shi JP
- Hosoda; Hiroshi - Kawasaki-shi JP
- Hosoda; Hiroshi - Minoo-shi JP
- Hosoda; Hiroshi - Kanagawa JP
- Hosoda; Hiroshi - Kanagawa-ken JP
| Patent | Date |
|---|---|
| Preventives or remedies for hepatopathy Grant 10,653,637 - Kangawa , et al. | 2020-05-19 |
| Medicament For Preventing Or Inhibiting Acute Kidney Injury App 20180280326 - Kangawa; Kenji ; et al. | 2018-10-04 |
| Medicament for suppressing malignant tumor metastasis Grant 10,071,099 - Kangawa , et al. September 11, 2 | 2018-09-11 |
| Method for suppressing malignant tumor metastasis Grant 9,987,333 - Kangawa , et al. June 5, 2 | 2018-06-05 |
| Modified ghrelin peptides Grant 9,938,332 - Kangawa , et al. April 10, 2 | 2018-04-10 |
| Modified ghrelin peptides Grant 9,573,986 - Kangawa , et al. February 21, 2 | 2017-02-21 |
| Medicinal Agent For Suppressing Malignant Tumor Metastasis App 20170035855 - Kangawa; Kenji ; et al. | 2017-02-09 |
| Medicament For Suppressing Malignant Tumor Metastasis App 20170014419 - KANGAWA; Kenji ; et al. | 2017-01-19 |
| Medicinal agent for suppressing malignant tumor metastasis Grant 9,486,503 - Kangawa , et al. November 8, 2 | 2016-11-08 |
| Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A and GC-B agonists Grant 9,233,143 - Kangawa , et al. January 12, 2 | 2016-01-12 |
| Medicinal Agent For Suppressing Malignant Tumor Metastasis App 20150258176 - Kangawa; Kenji ; et al. | 2015-09-17 |
| Coating Apparatus And Coating Method App 20140242284 - Shimai; Futoshi ; et al. | 2014-08-28 |
| Modified gherlin peptides Grant 8,524,871 - Kangawa , et al. September 3, 2 | 2013-09-03 |
| Modified Ghrelin Peptides App 20130172251 - KANGAWA; Kenji ; et al. | 2013-07-04 |
| Modified gherlin peptides Grant 8,227,570 - Kangawa , et al. July 24, 2 | 2012-07-24 |
| Modified Gherlin Peptides App 20110184153 - Kangawa; Kenji ; et al. | 2011-07-28 |
| Modified Gherlin Peptides App 20100240866 - KANGAWA; KENJI ; et al. | 2010-09-23 |
| Modified gherlin peptides App 20090170763 - Kangawa; Kenji ; et al. | 2009-07-02 |
| Modified ghrelin polypeptides Grant 7,385,026 - Kangawa , et al. June 10, 2 | 2008-06-10 |
| System, method, apparatus and program for collecting and providing information Grant 7,340,501 - Miida , et al. March 4, 2 | 2008-03-04 |
| Preventives or Remedies for Hepatopathy App 20070219114 - Kangawa; Kenji ; et al. | 2007-09-20 |
| Online shopping system and method App 20060085282 - Hanai; Atsushi ; et al. | 2006-04-20 |
| Online shopping system and method App 20060085281 - Hanai; Atsushi ; et al. | 2006-04-20 |
| System, method, apparatus and program for collecting and providing information App 20020049839 - Miida, Tetsuya ; et al. | 2002-04-25 |
| Online shopping system and method App 20010051893 - Hanai, Atsushi ; et al. | 2001-12-13 |
| Positive photoresist compositions and multilayer resist materials using the same Grant 5,728,504 - Hosoda , et al. March 17, 1 | 1998-03-17 |
| Positive-working quinonediazide photoresist composition containing a cyclohexyl-substituted triphenylmethane compound Grant 5,501,936 - Hosoda , et al. March 26, 1 | 1996-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 